Initiatives catalyzed by makeadent.org will be, i) novel, ii) longitudinal in effort (just not a firework), and iii) offered for free.
Our motivation is to decrease resource utilization, improve quality, and yet be frugal. These traits are inherent to the land of Gandhism, India, where innovation occurs out of necessity (due to resource limitedness).There is one word to describe it all (and a very popular one in the local language); its termed, “Jugaad.” (In fact, I recommend that all innovators read the book titled, “Jugaad Innovation.”)
Cardiovascular Science India Tour
Featuring world-class researchers from the U.S., the goal of this tour is to disseminate research methodology training to health care providers in India who want to conduct meaningful research that “makes a dent” in health care delivery and lives of less privileged people in several pockets of the country, both urban and rural.
CHAI (Cardiovascular Health in Asian Indians) Collaborative
Facilitating collaboration of experts —epidemiologists, statisticians, and geneticists to identify genetic markers of heightened atherosclerosis in South Asians. The fund will be established at the Cleveland Clinic, at the Department of Cardiovascular Medicine at Heart, Vascular and Thoracic Institute.
Ram and Sanjita Kalra Aavishqaar Fund
Cleveland Clinic Akron General is pleased to announce a fundraising campaign to support Cardiovascular Outcomes Research in Akron under the direction of Dr. Ankur Kalra, Chief of Cardiovascular Research.
Listen to Ankur’s conversations with legendary cardiologists, critical reviews of key congresses and late-breaking trials, and concise summaries of the best US Cardiology Review articles (we call them #AudioArticles!).
Published every second Monday of the month, this is your fix of reliable updates on all things cardiology by someone from a non-traditional background, who is always trying to look at it from new angles! Dear cardiologists, we want to make this podcast about you, and for you!
Patients undergoing transcatheter aortic valve replacement (TAVR) are at a higher risk of recurrent healthcare resource utilization due to multiple comorbidities, frailty, and advanced age. The 30-day all-cause readmission rate has been reported at 15-20%. We have devised a simple tool to identify patients at higher risk of 30-day readmission using the Nationwide Readmissions Databases (from January 2013 to September 2015).
This simple and easy-to-use risk prediction tool may help identify TAVR patients at increased risk of 30-day readmission, and aid in appropriate transition of care upon discharge and post-discharge follow-up.